| 商标名 | 通用名称 | 中文名称 | ATC编码 | 授权日期 | 上市许可持有人 | 市场状态 |
|---|---|---|---|---|---|---|
| Skilarence | dimethyl fumarate | 富马酸二甲酯 | L04AX07 | 2017-06-23 | Almirall S.A | Authorised |
| Numient | levodopa;carbidopa | 卡比多巴;左旋多巴 | N04BA02 | 2015-11-19 | Amneal Pharma Europe Ltd | Withdrawn |
| Actraphane | insulin human (rDNA) | 人胰岛素 | A10AD01 | 2002-10-07 | Novo Nordisk A/S | Authorised |
| Mimpara | cinacalcet | 盐酸西那卡塞 | H05BX01 | 2004-10-22 | Amgen Europe B.V. | Authorised |
| Jylamvo | methotrexate | 甲氨蝶呤 | L04AX03 | 2017-03-29 | Oresund Pharma ApS | Authorised |
| Pheburane | sodium phenylbutyrate | 苯丁酸钠 | A16AX03 | 2013-07-30 | Eurocept International B. V. | Authorised |
| Elucirem | gadopiclenol | 钆吡醇 | V08CA12 | 2023-12-07 | Guerbet | Authorised |
| Xelevia | sitagliptin | 磷酸西格列汀 | A10BH01 | 2007-03-21 | Merck Sharp & Dohme B.V. | Authorised |
| Edarbi | azilsartan medoxomil | 美阿沙坦 | C09CA09 | 2011-12-07 | Takeda Pharma A/S | Authorised |
| Possia | ticagrelor | 替格瑞洛 | B01AC24 | 2010-12-03 | AstraZeneca AB | Withdrawn |
| Elrexfio | elranatamab | 埃纳妥单抗 | 2023-12-07 | Pfizer Europe MA EEIG | Authorised | |
| Phelinun | melphalan | 盐酸美法仑 | L01AA03 | 2020-11-16 | ADIENNE S.r.l. S.U. | Authorised |
| Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) | lenalidomide | 盐酸来那度胺 | L04AX04 | 2021-02-11 | Krka, d.d., Novo mesto | Authorised |
| Hexyon | diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed) | J07CA09 | 2013-04-17 | Sanofi Winthrop Industrie | Authorised | |
| Viraferon | interferon alfa-2b | 干扰素α-2b | L03AB05 | 2000-03-09 | Schering-Plough Europe | Withdrawn |
| Epostim | epoetin alfa | 促红素α | Reliance GeneMedix Plc | Application withdrawn | ||
| Roctavian | valoctocogene roxaparvovec | 诺哌伏奥基 | B02BD15 | 2022-08-24 | BioMarin International Limited | Authorised |
| Xromi | hydroxycarbamide | 羟基脲 | L01XX05 | 2019-07-01 | Lipomed GmbH | Authorised |
| Gemesis | becaplermin | 贝卡普勒明 | BioMimetic Therapeutics Ltd | Refused | ||
| Enerzair Breezhaler | indacaterol;glycopyrronium bromide;mometasone | 格隆溴铵;茚达特罗;糠酸莫米松 | R03AL | 2020-07-03 | Novartis Europharm Limited | Authorised |
